Conventional insulin vs insulin infusion therapy in acute coronary syndrome diabetic patients

Table 3 Main glucose variability parameters measured in patients treated with conventional insulin or insulin-infused therapy

	Total	Conventional insulin treatment	Infusion insulin treatment	P value
	n = 44	n = 23	n = 21
Median of glycaemic values
Glycaemic values (first 24 h) mmol/L	10.3 (9.0; 12.1)o	10.1 (8.6; 11.6)	10.3 (9.2; 12.1)	0.716
Glycaemic values (overall hospitalization) mmol/L	10.2 (8.8; 11.5)	9.8 (8.7; 10.7)	10.6 (9.1; 11.5)	0.366
Glycaemic values (pre-discharge) mmol/L	9.3 (8.6; 10.2)	9.1 (8.5; 9.9)	9.4 (8.6; 11.4)	0.331
Median of glycaemic values variability (δ)
Variability of glycaemic values (first 24 h)	6.2 (4.5; 9.5)	5.7 (2.9; 7.5)	6.9 (5.5; 10.2)	0.045
Variability of glycaemic values (overall hospitalization)	9.9 (8.1; 13.1)	9.3 (7.3; 10.9)	10.9 (9.2; 14.3)	0.028
Variability of glycaemic values (pre-discharge)	5.2 (3.6; 6.1)	4.3 (2.9; 6.1)	5.3 (4.3; 6.8)	0.236
Median of glycaemic variability (Coefficient of Variation)
Glycaemic Coefficient of Variation (first 24 h)	21.4% (15.7%; 31.2%)	19.6% (12.6%; 29.6%)	23.1% (20.7%; 33.1%)	0.059
Glycaemic Coefficient of Variation (overall hospitalization)	25.3% (20.7%; 28.5%)	27.1% (20.7%; 30.1%)	24.9% (21.7%; 27.1%)	0.518
Glycaemic Coefficient of Variation (pre-discharge)	23.1% (17.0%; 28.5%)	23.1% (14.8%; 26.4%)	23.4% (17.9%; 29.1%)	0.466

^oInterquartile ranges (25^th; 75^th percentile) values reported in brackets.